| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $6.4B | $5.3B | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $1.5B | $1.5B | $1.9B | $1.8B | $1.7B | $1.4B | $1.2B |
| Operating Income | $0.3B | $0.3B | $0.6B | $0.0B | $0.0B | $0.1B | $0.0B |
| Net Income | $0.2B | $0.6B | $0.2B | $-0.3B | $-0.1B | $-0.1B | $-0.1B |
| EPS (Basic) | — | — | — | — | — | $-0.10 | $-0.20 |
| EPS (Diluted) | — | — | — | — | — | $-0.10 | $-0.20 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $16.1B | $16.0B | $17.9B | $16.9B | $16.1B | $16.1B | $17.2B |
| Current Assets | $1.0B | $1.0B | $1.7B | $1.0B | $1.0B | $0.6B | $0.9B |
| Cash & Equivalents | $0.1B | $0.0B | $0.3B | $0.0B | $0.2B | $0.0B | $0.4B |
| Total Liabilities | $12.3B | $12.2B | $14.4B | $13.6B | $13.1B | $12.9B | $13.0B |
| Current Liabilities | $1.3B | $1.5B | $2.7B | $1.7B | $1.3B | $1.1B | $1.0B |
| Stockholders' Equity | $3.8B | $3.8B | $3.4B | $3.2B | $3.0B | $3.2B | $4.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $1.7B | $1.9B | $1.6B | $1.4B | $1.9B | $1.8B |
| Investing Cash Flow | $-1.3B | $0.2B | $-1.5B | $-1.7B | $-1.1B | $-1.0B | $-1.7B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.5B | $-2.1B | $-0.0B | $-0.1B | $-0.1B | $-1.2B | $0.2B |